Search

Author/Creator Smith, Kelly T

1. A randomized pilot trial evaluating safety and immunogenicity of recMAGE-A3 + AS15 immunotherapeutic administered by intramuscular versus intradermal/subcutaneous routes. (6th November 2014)

Authors:
Slingluff, Craig L; Petroni, Gina R; Olson, Walter C; Chianese-bullock, Kimberly A; Smith, Kelly T; Smolkin, Mark E; Galeassi, Nadedja; Grosh, William; Weiss, Geoffrey; Scott, Kristy; Hornillo, Ana
Journal:
Journal for immunotherapy of cancer
Issue:
Volume 2(2014)Supplement 3
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. MHC-restricted phosphopeptide antigens: preclinical validation and first-in-humans clinical trial in participants with high-risk melanoma. Issue 1 (7th May 2020)

Authors:
Engelhard, Victor H; Obeng, Rebecca C; Cummings, Kara L; Petroni, Gina R; Ambakhutwala, Angela L; Chianese-Bullock, Kimberly A; Smith, Kelly T; Lulu, Amanda; Varhegyi, Nikole; Smolkin, Mark E; Myers, Paisley; Mahoney, Keira E; Shabanowitz, Jeffrey; Buettner, Nico; Hall, Emily H; Haden, Kathleen; ...
Journal:
Journal for immunotherapy of cancer
Issue:
Volume 8:Issue 1(2020)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. Phase I/II clinical trial of a helper peptide vaccine plus PD-1 blockade in PD-1 antibody-naïve and PD-1 antibody-experienced patients with melanoma (MEL64). Issue 9 (13th September 2022)

Authors:
Vavolizza, Rick Daniel; Petroni, Gina R; Mauldin, Ileana S; Chianese-Bullock, Kimberly A; Olson, Walter C; Smith, Kelly T; Dengel, Lynn T; Haden, Kathleen; Grosh, William W; Kaur, Varinder; Varhegyi, Nikole; Gaughan, Elizabeth M; Slingluff, Craig L
Journal:
Journal for immunotherapy of cancer
Issue:
Volume 10:Issue 9(2022)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

4. Pilot clinical trials testing the safety and effects on the metastatic melanoma microenvironment of intratumoral interferon-gamma or imiquimod, plus a multipeptide melanoma vaccine. (4th November 2015)

Authors:
Mauldin, Ileana S; Wages, Nolan A; Stowman, Anne M; Wang, Ena; Smolkin, Mark E; Olson, Walter C; Deacon, Donna H; Smith, Kelly T; Galeassi, Nadejda; Teague, Jessica E; Clark, Rachael A; Marincola, Francesco M; Petroni, Gina R; Mullins, David W; Slingluff, Craig L
Journal:
Journal for immunotherapy of cancer
Issue:
Volume 3(2015)Supplement 2
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

5. Trial to evaluate the immunogenicity and safety of a melanoma helper peptide vaccine plus incomplete Freund's adjuvant, cyclophosphamide, and polyICLC (Mel63). Issue 1 (21st January 2021)

Authors:
Slingluff, Jr., Craig L; Petroni, Gina R; Chianese-Bullock, Kimberly A; Wages, Nolan A; Olson, Walter C; Smith, Kelly T; Haden, Kathleen; Dengel, Lynn T; Dickinson, Anna; Reed, Caroline; Gaughan, Elizabeth M; Grosh, William W; Kaur, Varinder; Varhegyi, Nikole; Smolkin, Mark; Galeassi, Nadejda V; ...
Journal:
Journal for immunotherapy of cancer
Issue:
Volume 9:Issue 1(2021)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗